Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8+ T cells. - Wang X; Liu L; Yue T; Sun Z; Bae J; Tseng KF; Zhang A; Qiao J; Fu YX (Signal transduction and targeted therapy, 2023)